References
- Gemzell C., Wang C. F. Outcome of pregnancy in women with pituitary adenoma. Fertil. Steril. 1979; 31: 363–72
- Shupnik M. A., Baxter L. A., French L. R., Gorski J. In vivo effects of estrogen on ovine pituitaries: prolactin and growth hormone biosynthesis and messenger ribonucleic acid translation. Endocrinology 1979; 104: 729–35
- Rasmussen A. T. The weight of the principal components of normal hypophysis cerebri of adult human female. Am. J. Anat. 1934; 55: 253–75
- Scheithauer B., Santo T., Kovacs K., Young W., Ryan N., Randall R. The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin. Proc. 1990; 65: 461–74
- Molitch M. E. Pregnancy and the hyper-prolactinemic woman. N. Engl. J. Med. 1985; 312: 1364–70
- Abu-Fadil S., DeVane G., Siler T., Yen S. S. C. Effects of oral contraceptive steroids on pituitary prolactin secretion. Contraception 1976; 13: 79–85
- Corenblum B. The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia. Fed. Steril. 1993; 59: 671–3
- Woodhouse N. J.Y., Niles N., McDonald D., McCorkell S. Prolactin levels in pregnancy: comparison of normal subjects with patients having micro- or macroadenomas after early bromocriptine withdrawal. Horm. Res. 1986; 21: 1–9
- Radwanska E., McGarrigle H. H. G., Little V., Lawrence D., Sarris S., Swyer G. I. M. Induction of ovulation in women with hyperprolactinemic amenorrhea using clomiphene and human chorionic gonadotropin or bromocriptine. Fertil. Steril. 1979; 32: 187–92
- Swyer G. I. M., Little V., Harries B. J. Visual disturbance in pregnancy after induction of ovulation. Br. Med. J. 1971; 4: 90–1
- Jewelewicz R., Zimmermane A., Carmel P. W. Conservative management of a pituitary tumor during pregnancy following induction of ovulation with gonadotropins. Fertil. Steril. 1977; 28: 35–40
- Ruiz-Velasco V., Tolis G. Pregnancy in hyperprolactinemic women. Fertil. Steril. 1984; 41: 793–805
- Ahmed M., Al-Dossary E., Woodhouse N. J.Y. Macroprolactinomas with suprasellar extension: effect of bromocriptine withdrawal during one or more pregnancies. Fertil. Steril. 1992; 58: 492–7
- Crosignani P., Ferrari C., Mattei A. M. Visual field defects and reduced visual acuity during pregnancy in two patients with prolactinoma: rapid regression of symptoms under bromocriptine. Case reports. Br. J. Obstet. Gynaecol. 1984; 91: 821–3
- Molitch M. Management of prolactinomas. Ann. Rev. Men. 1989; 40: 225–32
- Magyar D. M., Marshall J. R. Pituitary tumors and pregnancy. Am. J. Obstet. Gynecol. 1978; 132: 739–51
- Lamberts S. W.J., Seldenrath H. J., Kwa H. G., Birkenhager J. C. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine. J. Clin. Endocrinol. Metab. 1977; 44: 180–4
- Maraschini C., Moro M., Masala A., Toja P., Alagna S., Brunani A., Rovasio P. P., Ginanni A., Lancranjan I., Cavagnini F. Chronic treatment with Parlodel Lar® of patients with prolactin-secreting tumours. Different responsiveness of micro- and macroprolactinomas. Acta Endocrinol. 1991; 125: 494–501
- Brue T., Pellegrini I., Priou A., Morange I., Jaquet P. Prolactinomas and resistance to dopamine agonists. Horm. Res. 1992; 38: 84–9
- Yousem D. M., Arrington J. A., Zinreich S. J., Jumar A., Bryan R. N. Pituitary adenomas: possible role of bromocriptine in intratumoral hemorrhage. Radiology 1989; 170: 239–43
- Verhelst J. A., Froud A. L., Touzel R., Wass J. A., Besser G. M., Grossman A. B. Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study. Acta Endocrinol. 1991; 125: 385–91
- Rasmussen C., Brownell J., Bergh T. Clinical response and prolactin concentration in hyperprolactinemic women during and after treatment for 24 months with the new dopamine agonist, CV 205–502. Acta Endocrinol. 1991; 125: 170–6
- Brue T., Pellegrini I., Gunz G., Morange I., Dewailly D., Brownell J., Enhalbert A., Jaquet P. Effects of the dopamine agonist CV205–502 in human prolactinomas resistant to bromocriptine. J. Clin. Endocrinol. Metab. 1992; 74: 577–84
- Pellegrini I., Rasolonjanahary R., Gunz G., Bertrand P., Delivet S., Jedynak C. P., Kordon C., Peillon F., Jaquet P., Enjalbert A. Resistance to bromocriptine in prolactinomas. J. Clin. Endocrinol. Metab. 1989; 69: 500–9